Novel JAK‐1 inhibitor upadacitinib as a possible treatment for refractory SAPHO syndrome: A case report
International Journal of Rheumatic Diseases · 2023-11 · 26 (11) · 2335-2337
DOI: 10.1111/1756-185x.14774 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of Rheumatic Diseases, online erschienen am 07.06.2023. Verfasst von Mingwei Ma und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Ch…. Hauptthemen laut MEDLINE: Acquired Hyperostosis Syndrome, Janus Kinase Inhibitors. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 8 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Rheumatology, Dongfang Hospital Beijing University of Chinese Medicine, Beijing, China.
- Department of Rheumatology, Fangshan Hospital Beijing University of Chinese Medicine, Beijing, China.
ORCID-Profile: Xiujuan Hou, Chen Li
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ma, M., Lu, S., Hou, X., & Li, C. (2023). Novel JAK‐1 inhibitor upadacitinib as a possible treatment for refractory SAPHO syndrome: A case report. International Journal of Rheumatic Diseases, 26(11), 2335-2337. https://doi.org/10.1111/1756-185x.14774
Vancouver
Ma M, Lu S, Hou X, Li C. Novel JAK‐1 inhibitor upadacitinib as a possible treatment for refractory SAPHO syndrome: A case report. International Journal of Rheumatic Diseases. 2023;26(11):2335-2337. doi:10.1111/1756-185x.14774
BibTeX
@article{Ma2023,
author = {Ma, Mingwei and Lu, Siyi and Hou, Xiujuan and Li, Chen},
title = {Novel JAK‐1 inhibitor upadacitinib as a possible treatment for refractory SAPHO syndrome: A case report},
journal = {International Journal of Rheumatic Diseases},
year = {2023},
volume = {26},
number = {11},
pages = {2335--2337},
doi = {10.1111/1756-185x.14774}
}
EUVIMED